SPY316.89-0.16 -0.05%
DIA261.17-1.83 -0.70%
IXIC10,488.73+55.08 0.53%

Arcturus Therapeutics To Be Added To Russell 2000 Index

SAN DIEGO, June 29, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc.((the "Company", "Arcturus", NASDAQ:ARCT), a leading clinical-stage messenger RNA medicines company focused on the

Benzinga · -

SAN DIEGO, June 29, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc.((the "Company", "Arcturus", NASDAQ:ARCT), a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, today announced thatit will be added to the Russell 2000®Index, as part of the 2020 Russell indexes reconstitution. The addition will be effective after the U.S. market opens on June 29, 2020 as part of the 2020 Russell U.S. Indexes annual reconstitution.